Literature DB >> 29750276

Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.

Noelle E Gillis1,2, Thomas H Taber1, Eric L Bolf1,2, Caitlin M Beaudet1, Jennifer A Tomczak1, Jeffrey H White1, Janet L Stein2,3, Gary S Stein2,3, Jane B Lian2,3, Seth Frietze2,4, Frances E Carr1,2.   

Abstract

Thyroid hormone receptor β (TRβ) suppresses tumor growth through regulation of gene expression, yet the associated TRβ-mediated changes in chromatin assembly are not known. The chromatin ATPase brahma-related gene 1 (BRG1; SMARCA4), a key component of chromatin-remodeling complexes, is altered in many cancers, but its role in thyroid tumorigenesis and TRβ-mediated gene expression is unknown. We previously identified the oncogene runt-related transcription factor 2 (RUNX2) as a repressive target of TRβ. Here, we report differential expression of BRG1 in nonmalignant and malignant thyroid cells concordant with TRβ. BRG1 and TRβ have similar nuclear distribution patterns and significant colocalization. BRG1 interacts with TRβ, and together, they are part of the regulatory complex at the RUNX2 promoter. Loss of BRG1 increases RUNX2 levels, whereas reintroduction of TRβ and BRG1 synergistically decreases RUNX2 expression. RUNX2 promoter accessibility corresponded to RUNX2 expression levels. Inhibition of BRG1 activity increased accessibility of the RUNX2 promoter and corresponding expression. Our results reveal a mechanism of TRβ repression of oncogenic gene expression: TRβ recruitment of BRG1 induces chromatin compaction and diminishes RUNX2 expression. Therefore, BRG1-mediated chromatin remodeling may be obligatory for TRβ transcriptional repression and tumor suppressor function in thyroid tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29750276      PMCID: PMC6692870          DOI: 10.1210/en.2018-00128

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

1.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 2.  Chromatin remodelling during development.

Authors:  Lena Ho; Gerald R Crabtree
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

Review 3.  When the SWI/SNF complex remodels...the cell cycle.

Authors:  C Muchardt; M Yaniv
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

4.  Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.

Authors:  Fumihiko Furuya; John A Hanover; Sheue-yann Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

5.  Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.

Authors:  Olaia Martínez-Iglesias; Susana Garcia-Silva; Stephan P Tenbaum; Javier Regadera; Fernando Larcher; Jesus M Paramio; Bjorn Vennström; Ana Aranda
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

6.  The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation.

Authors:  Susana García-Silva; Ana Aranda
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 7.  Thyroid receptor: roles in cancer.

Authors:  Ana Aranda; Olaia Martínez-Iglesias; Lidia Ruiz-Llorente; Verónica García-Carpizo; Alberto Zambrano
Journal:  Trends Endocrinol Metab       Date:  2009-08-26       Impact factor: 12.015

8.  The thyroid hormone receptor recruits NCoR via widely spaced receptor-interacting domains.

Authors:  Inna Astapova; Melissa F Dordek; Anthony N Hollenberg
Journal:  Mol Cell Endocrinol       Date:  2009-03-09       Impact factor: 4.102

9.  Negative regulation of TSHalpha target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation.

Authors:  Dongqing Wang; Xianmin Xia; Ying Liu; Alexis Oetting; Robert L Walker; Yuelin Zhu; Paul Meltzer; Philip A Cole; Yun-Bo Shi; Paul M Yen
Journal:  Mol Endocrinol       Date:  2009-02-05

Review 10.  The BRG1 transcriptional coregulator.

Authors:  Kevin W Trotter; Trevor K Archer
Journal:  Nucl Recept Signal       Date:  2008-02-01
View more
  9 in total

1.  Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer.

Authors:  Eric L Bolf; Noelle E Gillis; Cole D Davidson; Princess D Rodriguez; Lauren Cozzens; Jennifer A Tomczak; Seth Frietze; Frances E Carr
Journal:  Mol Cancer Res       Date:  2020-06-17       Impact factor: 5.852

Review 2.  Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer.

Authors:  A J Fritz; N E Gillis; D L Gerrard; P D Rodriguez; D Hong; J T Rose; P N Ghule; E L Bolf; J A Gordon; C E Tye; J R Boyd; K M Tracy; J A Nickerson; A J van Wijnen; A N Imbalzano; J L Heath; S E Frietze; S K Zaidi; F E Carr; J B Lian; J L Stein; G S Stein
Journal:  Genes Chromosomes Cancer       Date:  2019-03-15       Impact factor: 5.006

3.  Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.

Authors:  Eric L Bolf; Noelle E Gillis; Cole D Davidson; Lauren M Cozzens; Sophie Kogut; Jennifer A Tomczak; Seth Frietze; Frances E Carr
Journal:  Mol Carcinog       Date:  2021-09-17       Impact factor: 4.784

4.  The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.

Authors:  Eric L Bolf; Noelle E Gillis; Michael S Barnum; Caitlin M Beaudet; Grace Y Yu; Jennifer A Tomczak; Janet L Stein; Jane B Lian; Gary S Stein; Frances E Carr
Journal:  Horm Cancer       Date:  2019-12-21       Impact factor: 3.869

5.  A coregulator shift, rather than the canonical switch, underlies thyroid hormone action in the liver.

Authors:  Yehuda Shabtai; Nagaswaroop K Nagaraj; Kirill Batmanov; Young-Wook Cho; Yuxia Guan; Chunjie Jiang; Jarrett Remsberg; Douglas Forrest; Mitchell A Lazar
Journal:  Genes Dev       Date:  2021-02-18       Impact factor: 11.361

6.  OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.

Authors:  Xuhong Fu; Junjie Zhao; Guopeng Yu; Xiaomin Zhang; Jie Sun; Lingmeng Li; Jingyi Yin; Yinan Niu; Shancheng Ren; Yasheng Zhu; Bin Xu; Liyu Huang
Journal:  Commun Biol       Date:  2022-03-01

7.  Thyroid hormone dependent transcriptional programming by TRβ requires SWI/SNF chromatin remodelers.

Authors:  Noelle E Gillis; Joseph R Boyd; Jennifer A Tomczak; Seth Frietze; Frances E Carr
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 16.971

8.  Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms.

Authors:  Cole D Davidson; Eric L Bolf; Noelle E Gillis; Lauren M Cozzens; Jennifer A Tomczak; Frances E Carr
Journal:  J Endocr Soc       Date:  2021-06-01

9.  T3 Critically Affects the Mhrt/Brg1 Axis to Regulate the Cardiac MHC Switch: Role of an Epigenetic Cross-Talk.

Authors:  Francesca Forini; Giuseppina Nicolini; Claudia Kusmic; Romina D'Aurizio; Alberto Mercatanti; Giorgio Iervasi; Letizia Pitto
Journal:  Cells       Date:  2020-09-24       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.